Galactosidase Market Revenue, Key players, Trends, share and forecast till 2028

The size of the global galactosidase market was quite healthy in 2020, and it is anticipated to grow at a double-digit revenue CAGR throughout the forecast period. Increases in the geriatric population, the prevalence of chronic diseases, the frequency of genetic disorders like Fabry disease, and the increased prevalence of lactose intolerance among people all contribute to the market’s robust expansion. Other significant drivers of the worldwide galactosidase market growth include an increase in the number of genetic research carried out globally, an increase in pharmaceutical R&D activities and clinical trials, and rising demand across the food & beverage and pharmaceutical industries.

The enzyme galactosidase (also known as a glycoside hydrolase) serves as a catalyst in the breakdown of galactosides into monosaccharides. The two major categories of galactosidases are alpha- and beta-galactosidase. It is known that the alpha-galactosidase catalyses the hydrolysis of substrates containing -galactosidic residues, such as glycoproteins or glycosphingolipids. Contrarily, beta-galactosidase converts the monosaccharides glucose and galactose, which make up beta-galactosidase, from the disaccharide lactose. Galactooligosaccharides are used as a prebiotic ingredient in a variety of functional meals. They are created through the transfer reaction of alpha-galactosides. It is widely used as a biochemical tool for structure analysis in the biotechnology sector.

Get a sample copy of the report @

Top Players in the Global Galactosidase  Market:

Biocompare Inc., Prospec-Tany Technogene Ltd., Megazyme Ltd., JINAN BESTZYME BIOENGINEERING CO. LTD., Novozymes, Amano Enzyme, Inc., Advanced Enzymes, QA-Bio, Bestochem Formulations Ltd., ISU ABXIS, Pharming Group, Protalix Biotherapeutics, and Aumgene Biosciences

Alpha-galactosidase deficiency in leukocytes causes the rare genetic disorder Fabry disease in humans. Alpha-galactosidase-based enzyme replacement therapy is thus a successful cure for this illness. For the hydrolysis of lactose in milk or milk products, beta-galactosidase is an extensively utilised enzyme in the dairy industry. For patients who are lactose intolerant, it is also used to produce dairy products without lactose. Additionally, the cheese industry’s waste product, dairy whey, is frequently treated with this enzyme. Whey disposal has grown to be a significant environmental issue since it is dumped into water streams, seriously contaminating the water.

Read full report [email protected]

Market segmentation based on Product Type Outlook:

  • Alpha Galactosidase
  • Beta Galactosidase

Form Outlook:

  • Capsule
  • Tablet
  • Others

Application Outlook:

  • Food & Beverages
  • Pharmaceuticals
  • Pulp & paper
  • Feed
  • Others

Key Regional Markets Covered in the Report:

  • North America (U.S.A., Canada, Mexico)
  • Europe (Italy, U.K., Germany, France, Rest of Europe)
  • Asia Pacific (India, China, Japan, South Korea, Australia, Rest of Asia Pacific)
  • Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request a customized copy of the report @

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Browse More Reports

Butanediol Market:

Butanediol Market:

Chlorhexidine Gluconate Solution Market:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370

E-mail: [email protected]


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *